covid
Buscar en
Revista Médica del Hospital General de México
Toda la web
Inicio Revista Médica del Hospital General de México Paraneoplastic hypercalcaemia and osteolytic lesions secondary to large B-cell l...
Información de la revista
Vol. 81. Núm. S1.
Páginas 28-32 (abril 2018)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
2330
Vol. 81. Núm. S1.
Páginas 28-32 (abril 2018)
Clinical case
Open Access
Paraneoplastic hypercalcaemia and osteolytic lesions secondary to large B-cell lymphoma: Case report and literature review
Hipercalcemia paraneoplásica y lesiones osteolíticas secundarias a Linfoma B de células grandes: Reporte de caso y revisión de la literatura
Visitas
2330
Dora Luisa Covarrubias-Floresa, Ramón Adrián García-Galavizb,
Autor para correspondencia
raggs_0922@hotmail.com

Corresponding author.
, A. Silva-Carmonac
a Physician assigned to Unit 110 Internal Medicine, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico
b Resident Physician at Unit 110 Internal Medicine, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico
c Resident Physician, Pathology, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (5)
Mostrar másMostrar menos
Tablas (2)
Table 1. Lab test results.
Table 2. Immunohistochemistry results.
Mostrar másMostrar menos
Abstract
Introduction

Hypercalcaemia is a relatively common clinical finding, and its aetiology should be analysed in order to guide treatment.

Case report

56-year-old male presenting with hypercalcaemia, lumbar pain and osteolytic lesions in lumbar vertebrae, with large B-cell lymphoma subsequently confirmed by histology and immunohistochemistry.

Discussion

Common causes are primary hyperparathyroidism, hypercalcaemia associated with chronic kidney disease and paraneoplastic hypercalcaemia (secondary to malignancy). Less common causes are granulomatous diseases, lymphoma and vitamin D toxicity, all associated with vitamin D metabolism, and thyrotoxicosis associated with lithium or thiazide diuretic consumption.

Conclusion

Our patient presents with malignant hypercalcaemia, probably secondary to extra-renal conversion of 25(OH)D to 1,25-dihydroxyvitamin D, which represents <1% of cases.

Keywords:
Paraneoplastic hypercalcaemia
Lymphoma
Osteolytic lesions
Resumen
Introducción

Hipercalcemia es un hallazgo clínico relativamente común, deberá analizarse la etiología de la misma para normar conducta terapéutica.

Caso clínico

Se presenta a masculino de 56 años de edad que debuta con hipercalcemia, lumbalgia y lesiones osteolíticas en columna vertebral lumbar, al que posteriormente se le confirma linfoma b de células grandes mediante histología e inmunohistoquímica.

Discusión

Las principales causas son Hiperparatiroidismo primario, hipercalcemia asociada a enfermedad renal crónica e hipercalcemia paraneoplásica (secundaria a malignidad). Causas menos comunes son enfermedades granulomatosas, linfoma e intoxicación por Vitamina D, todas estas asociadas con el metabolismo de la Vitamina D; tirotoxicosis, asociada al consumo de litio o diuréticos tiazídicos.

Conclusión

Nuestro paciente debuta con hipercalcemia maligna, probablemente secundaria a la conversión extrarrenal de 25(OH)D a 1,25-dihidroxivitamina D, que representa <1% de los casos.

Palabras clave:
Hipercalcemia paraneoplásica
Linfoma
Lesiones osteolíticas
Texto completo

Hypercalcaemia is a relatively common clinical finding and its importance lies in its large variety of origins. The main causes are primary hyperparathyroidism, hypercalcaemia associated with chronic kidney disease and paraneoplastic hypercalcaemia (secondary to malignancy). Less common causes are granulomatous diseases, lymphoma and Vitamin D toxicity, all associated with vitamin D metabolism, and thyrotoxicosis, associated with lithium or thiazide diuretic consumption.1

Case report

56-year old male. From the State of Mexico. Has worked in a bodywork and paint shop for 28 years. Smoked for 4 years, 7 cigarettes per day, smoking index 1.4packs/year. Denies allergies, surgery, trauma and transfusions. Negative for exposure to tuberculosis. Negative for alcohol and substance abuse. Sexually active from the age of 16, 3 sexual partners, indistinct use of condom. No prior hospitalisations.

Onset 6 months before admission with abdominal pain located in mesogastrium and hypogastrium, subsequently irradiated to lumbar region, intermittent, diagnosed outside hospital as irritable bowel syndrome and treated with multiple regimens. Non-recorded fever predominantly in morning and night, no weight loss. Two months after onset of symptoms, dysuria, reduced micturition, increased frequency of urination and post-urination dripping. At the same time, disseminated dermatosis affecting the 4 limbs and front of abdomen, characterised by petechiae, lasting for 4 days, which resolved together with the aforementioned fever. Determination of prostate antigen in serum and a prostate ultrasound were ordered, finding values of 1ng/ml, enlarged prostate gland, smooth walls and no tumours.

Two weeks prior to admission, back pain increased in intensity with the addition of pain in right leg, which limits movement, so he visited Neurosurgery as an outpatient. An analgesic regimen with NSAIDs and gabapentin was initiated, with partial improvement, and a spinal MRI was ordered.

Back and leg pain increased again, so he decided to go to the ER, where oedema of the affected limb, erythema in the same area and pain upon palpation was found. It was decided to admit him with probable deep vein thrombosis. Uncompromised capillary fill and sensitivity. Non-painful, bilateral scrotal oedema. Blood test at admission: thrombocytopenia 107,000, acute kidney injury with creatinine 2.5 and urea 83.5, hyperuricaemia 13.3, ALT 114, AST 131, DHL 863, Sodium 140, potassium 3.3, chlorine 95, hypercalcaemia 12.8, phosphorous 6.4, magnesium 2.3. Evaluation requested from Angiology, which ordered venous Doppler ultrasound. Admitted to the Internal Medicine Department to continue management and diagnosis, with a working diagnosis of malignant hypercalcaemia.

At admission to Internal Medicine, simple X-rays of the spine in anteroposterior and lateral positions showed lytic lesions in the L4–L5 vertebrae. Management of hypercalcaemia started with hyper-hydration in the ER. Given the lack of response, a loop diuretic and dexamethasone were administered, also with no response. The calcium levels are shown in Table 1, together with their progression. Electrolytic imbalance and hypercalcaemia are particularly noteworthy, despite the aforementioned therapies. Also significant was the patient's renal failure since admission.

Table 1.

Lab test results.

Day  10  12 
Glucose  327  90  –  129  95  85  87 
Urea  72  72  –  107  83  59  59 
Creatinine  2.0  2.2  –  2.5  2.3  2.1  2.2 
Uric acid  10.3  10.9  –  12.2  –  –  9.9 
Sodium  140  148  138  140  141  140  139 
Potassium  4.7  4.0  2.9  3.5  2.4  2.9  3.5 
Chlorine  108  113  101  102  104  104  104 
Calcium (corrected)  10.2  13  14.2  13.6  12.8 (13.7)  12.7 (13.8)  13.2 (14.3) 
Phosphorous  4.7  4.9  5.9  3.8  2.2  2.8  3.2 
Magnesium  1.7  1.8  1.8  2.4  2.5  2.4  2.5 
Albumin  3.3  –  –  –  2.8  2.6  2.6 

The venous Doppler ultrasound of the right popliteal region showed deep vein thrombosis in the segment, so anticoagulation was started with low molecular weight heparin.

The spinal MRI scheduled prior to hospitalisation was performed, showing an apparently dependent lesion of both psoas, predominantly affecting the right side, involving the iliac psoas and right posterior spinal musculature, invasion of the spine through neural foramens L2–S1, wrapping around vascular structures of the aorta and inferior vena cava, right distal ureter with proximal dilation, and proximal dilation of the ipsilateral renal pelvis, suggesting a highly malignant tumour (Figs. 1–3).

Figure 1.

Sagittal MRI cut showing how the tumour affects the retroperitoneum and major vessels.

(0.19MB).
Figure 2.

Sagittal MRI cut showing spinal invasion.

(0.13MB).
Figure 3.

Sagittal MRI cut showing invasion and destruction of vertebrae.

(0.17MB).

An ultrasound-guided tumour biopsy was ordered. The biopsy revealed “Large B-cell lymphoma with germinal centre immunophenotype, with 30% proliferative index”. The immunohistochemistry is shown in Table 2, Figs. 4 and 5:

Table 2.

Immunohistochemistry results.

Antibody  Result 
CD3  Negative 
CD20  Positive 
BCL-6  Positive 
BCL-2  Positive 
MUM-1  Negative 
CD45  Positive 
ALK  Negative 
Ki67  30% positive 
Figure 4.

Microphotograph of haematoxylin/eosin stain.

(0.29MB).
Figure 5.

Microphotograph with immunohistochemistry showing CD20 positivity.

(0.34MB).
Discussion

The association of osteolytic lesions with lymphoma is found in 5–15% of cases, and hypercalcaemia and lymphoma in 10%. However, it is extremely rare for them to be the initial symptom of lymphoma (approximately 2%),2,3 hence the need to report such cases. The physiopathology is not fully known, although it is known that osteoclast activators such as MIP-1α, produced by tumour cells, are involved. These symptoms, however, can also be caused by other haematological diseases such as acute leukaemia (lymphoid and myeloid) and B-cell lymphoblastic lymphoma, etc.4,5

On a molecular level, the peptide related to the parathyroid hormone (PTHrP), inflammatory macrophage proteins 1α and 1β and calcitriol, have been related to lytic lesions and hypercalcaemia in lymphoma,6 giving these patients a poor prognosis.7

The importance of the treatment of malignant hypercalcaemia lies in the damage caused to the kidneys, the onset of which is a reduced response to the antidiuretic hormone, initially presented as inability to concentrate urine. The renal blood flow and glomerular filtration rate subsequently diminish due to severe calcium-induced vasoconstriction.1

In a review of the national literature, there is a single case of a 15-year-old patient with primary pre-B cell bone marrow lymphoma who, during the progression of his disease, presented hypercalcaemia and osteolytic lesions. He received the necessary treatment and achieved disease remission.3 Internationally, there is only one report of a 58-year-old woman with similar onset, with hypercalcaemia and osteolytic lesions. She was diagnosed with diffuse large B-cell lymphoma and was treated with a good outcome.8 We therefore highlight the importance of early diagnosis in order to start treatment regimens and improve the patient's quality of life and prognosis.

Ethical disclosureProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that no patient data appear in this article.

Right to privacy and informed consent

The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.

Conflicts of interest

The authors declare that they have no conflict of interests.

References
[1]
D. Endres.
Investigation of hypercalcemia.
Clin Biochem, 45 (2012), pp. 954-963
[2]
Y. Matsuhashi, T. Tasaka, E. Uehara, et al.
Diffuse large B-cell lymphoma presenting with hypercalcemia and multiple osteolysis.
Leuk Lymphoma, 45 (2004), pp. 397-400
[3]
M. Lobato, G. Ruiz-Argüelles, A. Ruíz-Argüelles.
Hipercalcemia y lesiones osteolíticas asociadas a linfoma primario de médula ósea de células pre B. Informe de un caso.
La Revista de Investigación Clínica Vol, 42 (1990), pp. 226-230
[4]
S. Iravani, T.P. Singleton, C.W. Ross, et al.
Precursor B lymphoblastic lymphoma presenting as lytic bone lesions.
Am J Clin Pathol, 112 (1999), pp. 836-843
[5]
S.K. Mandal, J. Ganguly, K. Sil, et al.
Diagnostic dilemma in a case of osteolytic lesions.
BMJ Case Rep, (2014),
[6]
B. Schöttker, W. Heinz, F. Weissinger, et al.
Parathyroid hormone-related protein-associated hypercalcemia in a patient with CLL type low grade leukemic B-cell lymphoma.
Haematologica, 91 (2006), pp. 119-122
[7]
H. Takasaki, H. Kanamori, M. Takabayashi, et al.
Non-Hodgkin's lymphoma presenting as multiple bone lesions and hypercalcemia.
Am J Hematol, 81 (2006), pp. 439-442
[8]
P. Chen, B. Li, W. Zhuang, et al.
Multiple bone lesions and hypercalcemia presented in diffuse large B cell lymphoma: mimicking multiple myeloma?.
Int J Hematol, 91 (2010), pp. 716-722
Copyright © 2016. Sociedad Médica del Hospital General de México
Descargar PDF
Opciones de artículo